Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35680829)

  • 1. [Analysis of Agranulocytosis Time and Its Influencing Factors in Patients with Hematological Malignancies Treated with rhIL-11 combined rhG-CSF].
    Wei HM; Li ZJ; Wang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):930-936. PubMed ID: 35680829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect and safety of pegylated recombinant human G-CSF on hematopoietic reconstitution after autologous hematopoietic stem cell transplantation in lymphoma patients].
    Shen YG; Ji MM; Zheng Z; Tang W; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2022 Nov; 43(11):940-945. PubMed ID: 36709186
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Different Dosages of rhG-CSF on Duration of Aleucocytosis and Leukocytes Level after Chemotherapy of Patients with Hematologic Malignancies].
    Gu YL; Xiao XC; Yang S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):398-402. PubMed ID: 28446282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
    Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study.
    Tian W; Wang Y; Zhou Y; Yao Y; Deng Y
    Front Oncol; 2022; 12():777602. PubMed ID: 35547875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].
    Liu KQ; Wang Y; Zhao Z; Lin D; Zhou CL; Liu BC; Gong XY; Zhao XL; Wei SN; Zhang GJ; Gong BF; Li Y; Liu YT; Mi YC; Wang JX; Wei H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):497-501. PubMed ID: 31340623
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.
    Grzegorzewski KJ; Komschlies KL; Franco JL; Ruscetti FW; Keller JR; Wiltrout RH
    Blood; 1996 Dec; 88(11):4139-48. PubMed ID: 8943848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].
    Ma YC; Li M; Xing S; Xiong GL; Shen X; Chen Q; Cong YW; Wang JX; Zhu NK; Yu ZY; Zhang XG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):573-9. PubMed ID: 27151032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of recombinant human interleukin 11 and granulocyte colony stimulating factor in mobilization for autologous peripheral blood stem cell transplantation].
    Zhu HY; DA WM; Gao CJ; Wang FF; Han XP; Li HH; Huang WR; Zhang YZ; Wang SH; Bo J; Jing Y; Jin HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):345-9. PubMed ID: 18426662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in peripheral blood progenitor cells in primates by coadministration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Ikebuchi K; Wada Y; Okano A; Nakamiya T; Akiyama Y; Sawada T; Asano S; Nakahata T
    Transplantation; 1997 Nov; 64(10):1468-73. PubMed ID: 9392313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
    Cairo MS; Plunkett JM; Nguyen A; Clark S; van de Ven C
    Pediatr Res; 1991 Dec; 30(6):554-9. PubMed ID: 1725208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.